- Women's Health
When Science Evolves, Trust Matters in Women’s Health
At the 2026 STAT Summit in Boston, Dr. Kristie Baisden of Bayer joined STAT editor Torie Bosch to discuss science, women’s health and the fight against misinformation.
Dr. Baisden’s central message was clear: trust in women’s health starts with transparency. Women need timely, understandable and evidence-based health information. They also need healthcare professionals who listen, acknowledge uncertainty and explain how scientific evidence may apply to each person.
Women’s health is at an inflection point. Menopause is receiving long-overdue attention, but awareness alone does not improve health outcomes. Progress requires action across research, education, policy, access and care—and a commitment to moving evidence into clinical practice.
At a glance
- Trust in women’s health depends on transparent, evidence-based communication.
- Menopause and contraception decisions should be individualized through shared decision-making with healthcare professionals.
- Health misinformation should be answered with credible evidence, clear context and open dialogue.
- Research improves outcomes only when evidence reaches clinical practice and the people it is intended to serve.
Trust, women’s health and misinformation
Women have access to more health information than ever, but not all of it is accurate, balanced or evidence-based. Social media can amplify compelling personal stories alongside claims that lack context or scientific support. The goal is not to meet hype with more hype. It is to help women identify credible information and make decisions with confidence.
Contraception illustrates the challenge. Online skepticism and misinformation can complicate counseling and create uncertainty about well-established options. Access to contraception is a personal healthcare decision. Women should have clear information about benefits, risks and alternatives, together with an open conversation with a healthcare professional.
Evidence-based, individualized menopause care
Evidence-based care starts with a simple principle: every woman’s journey is different. Women need clear information about their options, and clinicians need practical tools to support personalized decisions based on symptoms, medical history, preferences and goals.
Menopause misinformation can contribute to confusion and undertreatment. Hormone therapy remains an important option for many women, but treatment decisions should be individualized and discussed with a qualified healthcare professional. The right question is not whether one approach is right for everyone; it is how the best available evidence applies to the person seeking care. The Menopause Society statement on hormone therapy misinformation
New guidance from the American College of Obstetricians and Gynecologists expands evidence-based recommendations for menopause-related hot flashes, night sweats, sleep disruption and mood symptoms, covering both hormonal and nonhormonal treatment options. ACOG emphasizes shared decision-making: treatment choices should consider each patient’s symptoms, age, medical history, individual risks and personal goals. Read ACOG’s announcement on the expanded menopause recommendations.
Why scientific guidance evolves
Scientific guidance evolves as new data emerge, researchers refine their understanding and healthcare professionals learn which approaches work best for different people. That evolution is not a weakness of science; it is science working as intended.
The history of menopausal hormone therapy shows why transparent explanation matters. The 2002 Women’s Health Initiative findings changed perceptions of treatment. Later analyses and additional evidence refined understanding of benefits, risks, timing and differences among patient populations. Explaining what changed, why it changed and how it may apply to an individual is essential to maintaining trust. Read the federal announcement on updated hormone-therapy labeling.
Moving menopause evidence into practice
Menopause symptoms can substantially affect quality of life. Bayer educational materials report that up to 80% of women experience vasomotor symptoms such as hot flashes and night sweats, and up to 40% report moderate-to-severe symptoms that disrupt daily life. Yet many women still lack access to clear, trusted information about treatment options.
Source: Bayer educational material, Info Nugget: Talk Menopause
Research creates value when credible evidence reaches healthcare professionals and the women they serve. That requires education, practical clinical tools and collaboration among researchers, healthcare professionals, industry, policymakers, patient advocates and communicators.
Shared decision-making in women’s health
Shared decision-making pairs the best available evidence with each woman’s lived experience, symptoms, needs, preferences and goals. It depends on a two-way conversation: listening without judgment, acknowledging uncertainty and clearly explaining benefits, risks and alternatives.
Bayer’s role is not only to advance innovation, but also to communicate science with integrity and transparency. Clear communication helps women participate actively in their care and choose an approach that aligns with their individual health needs and goals.
- Trust starts with transparency. Explain what is known, what is changing and how evidence applies to each person.
- Care should be evidence-based and individualized. Consider symptoms, medical history, risks, preferences and goals.
- Shared decision-making is a two-way process. Discuss treatment benefits, risks and alternatives clearly.
- Answer misinformation with credible evidence. Provide timely facts, context and open dialogue.
- Move evidence into practice. Connect research, education, clinical tools, policy and access to improve women’s health.
A final perspective on trust and science
“Trust is built when science is transparent. In women’s health, our responsibility is not only to advance innovation, but to clearly explain how evidence evolves so women can make informed choices with confidence. When we combine scientific rigor with clear communication and shared decision-making, we help women make the decisions that are right for them.”
Science Delivers answers, hope and progress
Bayer’s Science Delivers initiative invites Americans to celebrate science’s impact and challenge misinformation. In women’s health, that means championing evidence-based decision-making, helping people recognize credible information and supporting the conditions that allow rigorous research to improve care.
Science delivers more than solutions. It delivers breakthroughs that can heal, protect and empower—and its impact is strongest when evidence is communicated clearly and people can participate confidently in decisions about their health.